IL146432A0 - A tetrapeptide and a pharmaceutical composition containing the same - Google Patents
A tetrapeptide and a pharmaceutical composition containing the sameInfo
- Publication number
- IL146432A0 IL146432A0 IL14643200A IL14643200A IL146432A0 IL 146432 A0 IL146432 A0 IL 146432A0 IL 14643200 A IL14643200 A IL 14643200A IL 14643200 A IL14643200 A IL 14643200A IL 146432 A0 IL146432 A0 IL 146432A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrapeptide
- seq
- proposed
- substance
- glu
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU99108841/14A RU2157233C1 (ru) | 1999-05-11 | 1999-05-11 | Тетрапептид, обладающий геропротекторной активностью, фармакологическое средство на его основе и способ его применения |
PCT/RU2000/000012 WO2000068255A2 (en) | 1999-05-11 | 2000-01-20 | Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146432A0 true IL146432A0 (en) | 2002-07-25 |
Family
ID=20219149
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14643200A IL146432A0 (en) | 1999-05-11 | 2000-01-20 | A tetrapeptide and a pharmaceutical composition containing the same |
IL146432A IL146432A (en) | 1999-05-11 | 2001-11-11 | Tetrapeptide and pharmaceuticalcomposition containing the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL146432A IL146432A (en) | 1999-05-11 | 2001-11-11 | Tetrapeptide and pharmaceuticalcomposition containing the same |
Country Status (11)
Country | Link |
---|---|
US (1) | US6727227B1 (xx) |
EP (1) | EP1179008B1 (xx) |
JP (1) | JP3902406B2 (xx) |
AT (1) | ATE321068T1 (xx) |
AU (1) | AU769847C (xx) |
CA (1) | CA2373128C (xx) |
DE (1) | DE60026826T2 (xx) |
ES (1) | ES2259998T3 (xx) |
IL (2) | IL146432A0 (xx) |
RU (1) | RU2157233C1 (xx) |
WO (1) | WO2000068255A2 (xx) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8680059B2 (en) * | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
US7175679B2 (en) * | 2001-03-29 | 2007-02-13 | Biotempt B.V. | Oligopeptide treatment of NF-κB mediated inflammation |
US6844315B2 (en) * | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
EP1138692A1 (en) * | 2000-03-29 | 2001-10-04 | Erasmus Universiteit Rotterdam | Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
US6921751B1 (en) * | 1998-05-20 | 2005-07-26 | Erasmus Universiteit Rotterdam | Immunoregulator |
US20040202645A1 (en) * | 2003-04-08 | 2004-10-14 | Khan Nisar Ahmed | Administration of gene-regulatory peptides |
US20050227925A1 (en) * | 2004-04-08 | 2005-10-13 | Robbert Benner | Compositions capable of reducing elevated blood urea concentration |
US7358330B2 (en) | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
USRE43279E1 (en) | 2000-03-29 | 2012-03-27 | Biotemp B.V. | Compositions capable of reducing elevated blood urea concentration |
EP1300418A1 (en) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
US7576174B2 (en) * | 2000-03-29 | 2009-08-18 | Biotempt B.V. | Compositions capable of reducing elevated blood urea concentration |
RU2161501C1 (ru) * | 2000-06-29 | 2001-01-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Способ получения пептидов, обладающих тканеспецифической активностью, и фармацевтические композиции на их основе |
WO2002090380A1 (en) * | 2001-04-17 | 2002-11-14 | Sankt-Peterburgskaya Obschestvennaya Organizatsiya 'institut Bioregulyatsii I Gerontologii Czo Ramn' | Tetrapeptide stimulating the retinal function and the method of its application |
US20030220261A1 (en) * | 2001-12-21 | 2003-11-27 | Khan Nisar Ahmed | Treatment of iatrogenic disease |
US20030224995A1 (en) * | 2001-12-21 | 2003-12-04 | Khan Nisar Ahmed | Treatment of burns |
US20080318871A1 (en) * | 2001-12-21 | 2008-12-25 | Khan Nisar A | Treatment of neurological disorders |
US7560433B2 (en) * | 2001-12-21 | 2009-07-14 | Biotempt B.V. | Treatment of multiple sclerosis (MS) |
US20040013661A1 (en) * | 2001-12-21 | 2004-01-22 | Gert Wensvoort | Stratification |
US7501391B2 (en) | 2001-12-21 | 2009-03-10 | Biotempt B.V. | Treatment of transplant survival |
US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
US7786084B2 (en) * | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
US20030220257A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of trauma |
US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
RU2255757C1 (ru) * | 2004-06-22 | 2005-07-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Пептидное соединение, восстанавливающее функцию органов дыхания |
SG163567A1 (en) * | 2005-07-05 | 2010-08-30 | Biotempt Bv | Treatment of tumors |
EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
RU2304444C1 (ru) * | 2006-05-23 | 2007-08-20 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения |
RU2295970C1 (ru) * | 2006-05-23 | 2007-03-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, повышающий резистентность капилляров, фармацевтическая композиция на его основе и способ ее применения |
RU2301678C1 (ru) | 2006-05-30 | 2007-06-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения |
RU2301074C1 (ru) * | 2006-05-30 | 2007-06-20 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, обладающий иммуногеропротекторным действием, фармацевтическая композиция на его основе и способ ее применения |
CA2677948C (en) * | 2007-02-12 | 2014-12-09 | Biotempt B.V. | Treatment of trauma-hemorrhage with short oligopeptides |
RU2464816C1 (ru) * | 2011-04-14 | 2012-10-27 | Общество с ограниченной ответственностью "Вилави" | Композиция биологически активных веществ, обладающая геропротекторной активностью, и способ комплексной коррекции возрастных изменений гормонального баланса, функций эпифиза и антиоксидантного статуса, включающий введение указанной композиции |
CN107708711A (zh) * | 2015-05-22 | 2018-02-16 | 艾尔牛奶有限公司 | β‑酪蛋白A2和抗氧化能力 |
AU2021256034A1 (en) * | 2020-04-15 | 2022-09-29 | Lactocore, Inc. | Synthetic peptides for modulating the metabotropic glutamate receptor 5 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0851980A (ja) * | 1994-08-11 | 1996-02-27 | Asahi Glass Co Ltd | 合成遺伝子およびこれを用いた癌転移阻害活性を有するペプチドの製造方法 |
-
1999
- 1999-05-11 RU RU99108841/14A patent/RU2157233C1/ru not_active IP Right Cessation
-
2000
- 2000-01-20 IL IL14643200A patent/IL146432A0/xx active IP Right Grant
- 2000-01-20 EP EP00905499A patent/EP1179008B1/en not_active Expired - Lifetime
- 2000-01-20 JP JP2000616229A patent/JP3902406B2/ja not_active Expired - Fee Related
- 2000-01-20 AU AU27034/00A patent/AU769847C/en not_active Ceased
- 2000-01-20 CA CA002373128A patent/CA2373128C/en not_active Expired - Fee Related
- 2000-01-20 ES ES00905499T patent/ES2259998T3/es not_active Expired - Lifetime
- 2000-01-20 US US09/959,852 patent/US6727227B1/en not_active Expired - Fee Related
- 2000-01-20 DE DE60026826T patent/DE60026826T2/de not_active Expired - Lifetime
- 2000-01-20 WO PCT/RU2000/000012 patent/WO2000068255A2/en active Search and Examination
- 2000-01-20 AT AT00905499T patent/ATE321068T1/de active
-
2001
- 2001-11-11 IL IL146432A patent/IL146432A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2000068255A3 (en) | 2001-06-14 |
DE60026826D1 (de) | 2006-05-11 |
IL146432A (en) | 2007-06-03 |
AU769847B2 (en) | 2004-02-05 |
RU2157233C1 (ru) | 2000-10-10 |
JP2003526622A (ja) | 2003-09-09 |
DE60026826T2 (de) | 2007-04-12 |
US6727227B1 (en) | 2004-04-27 |
ES2259998T3 (es) | 2006-11-01 |
EP1179008B1 (en) | 2006-03-22 |
AU769847C (en) | 2005-02-17 |
CA2373128C (en) | 2007-03-13 |
JP3902406B2 (ja) | 2007-04-04 |
CA2373128A1 (en) | 2000-11-16 |
ATE321068T1 (de) | 2006-04-15 |
WO2000068255A2 (en) | 2000-11-16 |
AU2703400A (en) | 2000-11-21 |
EP1179008A2 (en) | 2002-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146432A0 (en) | A tetrapeptide and a pharmaceutical composition containing the same | |
IL149243A0 (en) | Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same | |
HU0102272D0 (en) | Compositions and methods for stimulating gastrointestinal motilis | |
IL140412A0 (en) | L-lys -l-glu dipeptides for pharmaceutical preparations | |
ES2166270A1 (es) | Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona. | |
TW369535B (en) | A pyrazolopyridine compound and the process for preparing thereof | |
UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
GB9914486D0 (en) | Medicaments | |
GEP20094723B (en) | Tetraazabenzo [e] azulene derivatives and analogs thereof | |
HK1054196A1 (en) | Pharmaceutical formulation containing tolterodine and its use | |
NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
IL194500A0 (en) | Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application | |
RS91204A (xx) | Tečni preparat koji sadrži derivat kamptotecina i farmaceutski preparat koji se može dobiti liofilizacijom ovog preparata | |
IL194499A0 (en) | Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application | |
WO2007136295A3 (en) | Peptide substance revealing a stress protective effect, pharmaceutical composition on its base and the method of its application | |
WO2005014032A3 (en) | Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite | |
MX9806229A (es) | Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas. | |
CA2382654A1 (en) | Novel a-500359 derivatives | |
WO2004058303A3 (en) | Compositions of benzoquinolizine carboxylic acid antibiotic drugs | |
AU2002351536A1 (en) | Analogs of human growth hormone-releasing hormone, their preparation and use | |
RU94032285A (ru) | Цефалоспориновые соединения, способ их получения, фармацевтическая композиция | |
RU2002125463A (ru) | Полипептидное соединение, способы его получения, фармацевтическая композиция и способ профилактики или лечения грибковых заболеваний | |
CA2425445A1 (en) | Tetrapeptide stimulating functional activity of hepatocytes, pharmacological substance on its basis and the method of its application | |
MXPA02006034A (es) | Formas de dosis mucosaloral de apomorfina. | |
CA2547873A1 (en) | Tetrapeptide regulating blood glucose level in diabetes mellitus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |